Attached files

file filename
10-K - FORM 10-K - ImmunoCellular Therapeutics, Ltd.d10k.htm
EX-10.33 - LICENSE AGREEMENT - ImmunoCellular Therapeutics, Ltd.dex1033.htm
EX-10.34 - EMPLOYMENT AGREEMENT - ImmunoCellular Therapeutics, Ltd.dex1034.htm
EX-10.35 - EMPLOYMENT AGREEMENT - ImmunoCellular Therapeutics, Ltd.dex1035.htm
EX-31.1 - CERTIFICATION OF THE REGISTRANT'S PRINCIPAL EXECUTIVE OFFICER - ImmunoCellular Therapeutics, Ltd.dex311.htm
EX-32.2 - CERTIFICATION OF THE PRINCIPAL FINANCIAL OFFICER - ImmunoCellular Therapeutics, Ltd.dex322.htm
EX-32.1 - CERTIFICATION OF THE REGISTRANT'S PRINCIPAL EXECUTIVE OFFICER - ImmunoCellular Therapeutics, Ltd.dex321.htm
EX-31.2 - CERTIFICATION OF THE REGISTRANT'S PRINCIPAL FINANCIAL OFFICER - ImmunoCellular Therapeutics, Ltd.dex312.htm
EX-10.36 - AGREEMENT BETWEEN DR. JOHN YU AND IMMUNOCELLULAR - ImmunoCellular Therapeutics, Ltd.dex1036.htm

EXHIBIT 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We consent to the incorporation by reference in the following Registration Statements:

1. Registration Statement (Form S-8 No. 333-155199) pertaining to the 2006 Equity Incentive Plan;

2. Registration Statement (Form S-8 No. 333-151968) pertaining to the 2006 Equity Incentive Plan; and

3. Registration Statement (Form S-8 No. 333-150277) pertaining to the 2006 Equity Incentive Plan;

and related Prospectuses of ImmunoCellular Therapeutics, Ltd. of our report of Independent Registered Public Accounting Firm dated March 29, 2010 covering the financial statements of ImmunoCellular Therapeutics, Ltd. as of December 31, 2008 and 2009 and for the years ended December 31, 2007, 2008 and 2009 and for the period from inception of operations (February 25, 2004) to December 31, 2009.

/s/ STONEFIELD JOSEPHSON, INC.

Los Angeles, California

March 29, 2010